OrthoPediatrics Q2 revenue hits record $61.1M (+16% YoY); raises FY2025 guidance

ORTHOPEDIATRICS CORP

2025-Q2 EPS reported -$0.76 revenue$113,493,000

Revenue of $61.1M (+16% YoY); domestic up 17%, international up 12%.
Adjusted EBITDA $4.1M (+58% YoY); non-GAAP EPS improved to ($0.11) from ($0.23).
Raised FY2025 revenue guidance to $237-242M from $236-242M; reaffirmed adjusted EBITDA $15-17M.
Scoliosis revenue +35% to $18.5M; Trauma & Deformity +10% to $41.7M.
OPSB expanded with new clinics, entry into Ireland for first international operation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.